再生元 (Regeneron)：我不担心资产回报率 (ROIC) 和营业利润率的下降 (NASDAQ:REGN)
· seekingalpha.com
再生元制药公司 (Regeneron Pharmaceuticals, Inc.) 买入案例：尽管存在波动性和 Eylea 生物类似药风险，Dupixent 和 Libtayo 仍推动了增长；利润率有望恢复。点击阅读 REGN 最新动态。
Regeneron Pharmaceuticals, Inc. ( REGN ), based in Tarrytown, NJ, is a leading biotechnology company with a fantastic track-record of rewarding shareholders ove...